The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension

The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in... Ir J Med Sci (2017) 186:621–629 DOI 10.1007/s11845-017-1580-5 ORIGINAL ARTICLE The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension 1 2 1 1 2 3 • • • • • • V. Buda M. Andor C. Cristescu M. Voicu F. Cochera P. Tuduce 4 2 L. Petrescu M. C. Tomescu Received: 10 August 2016 / Accepted: 7 February 2017 / Published online: 21 February 2017 Royal Academy of Medicine in Ireland 2017 Abstract Methods A total of 365 patients were included in the Background In the last decades, the studies performed on study: 127 hypertensive patients were under treatment with the field of endothelial dysfunction confirmed the fact that candesartan, 134 patients were under treatment with other the starting point of this pathology is the inflammation. hypotensive medication (beta blockers, calcium channel Several inflammatory biomarkers had been discovered and blockers, and diuretics), both groups with controlled values studied, ones showing systemic inflammation, and others of blood pressure, and 104 were normotensive persons. being more specific biomarkers and showing the local Classical methods of assessing the endothelial function inflammation. Pentraxin-3 (PTX3) is a new inflammatory were correlated with these biochemical http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Irish Journal of Medical Science (1971 -) Springer Journals

The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension

Loading next page...
 
/lp/springer_journal/the-effect-of-candesartan-on-pentraxin-3-plasma-levels-as-marker-of-lRK1eVi1er
Publisher
Springer London
Copyright
Copyright © 2017 by Royal Academy of Medicine in Ireland
Subject
Medicine & Public Health; Internal Medicine; General Practice / Family Medicine
ISSN
0021-1265
eISSN
1863-4362
D.O.I.
10.1007/s11845-017-1580-5
Publisher site
See Article on Publisher Site

Abstract

Ir J Med Sci (2017) 186:621–629 DOI 10.1007/s11845-017-1580-5 ORIGINAL ARTICLE The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension 1 2 1 1 2 3 • • • • • • V. Buda M. Andor C. Cristescu M. Voicu F. Cochera P. Tuduce 4 2 L. Petrescu M. C. Tomescu Received: 10 August 2016 / Accepted: 7 February 2017 / Published online: 21 February 2017 Royal Academy of Medicine in Ireland 2017 Abstract Methods A total of 365 patients were included in the Background In the last decades, the studies performed on study: 127 hypertensive patients were under treatment with the field of endothelial dysfunction confirmed the fact that candesartan, 134 patients were under treatment with other the starting point of this pathology is the inflammation. hypotensive medication (beta blockers, calcium channel Several inflammatory biomarkers had been discovered and blockers, and diuretics), both groups with controlled values studied, ones showing systemic inflammation, and others of blood pressure, and 104 were normotensive persons. being more specific biomarkers and showing the local Classical methods of assessing the endothelial function inflammation. Pentraxin-3 (PTX3) is a new inflammatory were correlated with these biochemical

Journal

Irish Journal of Medical Science (1971 -)Springer Journals

Published: Feb 21, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off